Notably, IL17a identified alterations in signaling by ERBB2 factors, which is a pathway of particular relevance to schizophrenia given its interaction with neuregulin-1 to mediate cell adhesion [95], its potential role in schizophrenia risk [96], as well as antipsychotic response/treatment [97]. The gene discussed is IL17A; the disease is schizophrenia.